Advanced search for publications
Enter your keywords
Shared care protocol – leflunomide in adults
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Shared care protocol – methotrexate in adults (excluding cancer)
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Shared care protocol – dexamfetamine in adults
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Shared care protocol – lisdexamfetamine in children and adults
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Shared care protocol – sulfasalazine in adults
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Shared care protocol – lithium in adults
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Shared care protocol – atomoxetine in children and adults
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Formulary assessment – levodopa inhalation powder (Inbrija)
Formulary assessment tools are templates to support local decision making. They list NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies. The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The […]
Shared care protocol – hydroxychloroquine for adults
This shared care protocol is based on the version published nationally by NHS England. The clinical content has been reviewed against current national guidance, and updated accordingly on the date indicated in the document. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB […]
Switching from disposable to reusable insulin pens
This document outlines the benefits of appropriate switching from disposable to reusable insulin pens, highlighting advantages for patients, the environment, and potential cost savings. It also provides practical recommendations for implementation by medicines optimisation teams